Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



P&G Inches Forward

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Slowly, very slowly, Procter & Gamble (NYSE: PG  ) is crawling out of consumer-staples purgatory. But don't be fooled -- the world's largest consumer products company has a long way to go before it reaches growth nirvana.

When we last checked in with P&G between quarterly reports, the company was busy slashing prices and realigning its product portfolio to compete a bit more on a value platform. It's too soon to judge the results of that strategy, but consumers already appear less shell-shocked -- a phenomenon that was perhaps telegraphed by Costco's (NYSE: COST  ) earlier results, and is more recently corroborated by Colgate-Palmolive's (NYSE: CL  ) quarter.

Net sales of $19.8 billion for P&G's fiscal-2010 first quarter represent a 6% year-over-year decline, owing mostly to a stronger dollar. However, organic sales, which exclude currency effects, rose 2%, beating management's previous guidance of flat to down 3%. Earnings per share also trumped company expectations, climbing 3% to $1.06. Notably, both the top- and bottom-line numbers showed sequential growth.

Of course, it's always nice to see that a company can lift revenue via price increases. But the key metric for judging fundamental business health is volume, and on an organic basis, P&G sold 2% fewer products. On the one hand, that's an encouraging number, as it shows significant improvement from the prior quarter. Still, "over half" of the volume decline was driven by softness in the company's developing and emerging markets regions, where the company increased prices to bolster margins.

In recent years, these corners of the globe have been the holy grail for global consumer-goods companies such as P&G, Johnson & Johnson (NYSE: JNJ  ) , and Kimberly Clark (NYSE: KMB  ) , with rising middle classes fueling sales growth. P&G's price increases, however, seem to have turned away some of these otherwise eager consumers. To be fair, competitor Colgate-Palmolive saw much of the same effect in its recent quarter, but it nonetheless managed to grow volume on the whole.

So is there any decidedly good news for P&G shareholders? You bet.

On the conference call, management described impressive initial results for many premium-level product innovations. More importantly, from my perspective, management also spoke at great length about "cost innovation" and "value-tier offerings." Crest Pro Health is a perfect example; the company's been able to pass along to the consumer newly realized production savings. It appears that P&G is finally recognizing that it can't excel with consumers by sounding a one-note premium message.

Finally, management lifted the low end of full-year EPS guidance by $0.03 per share, to a range of $4.02-$4.12. Regarding the current quarter, the company sees organic sales growth at 2%-5%, which would be flat to positive versus the just-reported period.

I haven't been keen on P&G in the past year, instead recommending that investors eye shares of Church & Dwight (NYSE: CHD  ) or Clorox (NYSE: CLX  ) , among others. And although I'm far from convinced that P&G can deliver industry-beating growth in the near-term, its apparent new focus on consumer value could lead to some well-groomed profits down the road.  

Related Foolishness:

Procter & Gamble, Clorox, Johnson & Johnson, and Kimberly Clark are Motley Fool Income Investor selections. Costco is a choice of Stock Advisor and Inside Value. The Fool owns shares of Procter & Gamble and Costco. Try any of our Foolish newsletter services free for 30 days.

Fool contributor Mike Pienciak owns shares of Church & Dwight, but he holds no beneficial interest in any other company mentioned in this article. The Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (10)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1027024, ~/Articles/ArticleHandler.aspx, 10/25/2016 11:41:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,178.04 -44.99 -0.25%
S&P 500 2,145.49 -5.84 -0.27%
NASD 5,289.53 -20.30 -0.38%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 11:25 AM
PG $87.77 Up +3.67 +4.36%
Procter and Gamble CAPS Rating: ****
CHD $48.10 Up +0.77 +1.62%
Church and Dwight CAPS Rating: ***
CL $71.55 Up +0.52 +0.73%
Colgate-Palmolive CAPS Rating: ****
CLX $120.11 Up +1.45 +1.22%
The Clorox Company CAPS Rating: ****
JNJ $113.72 Up +0.11 +0.10%
Johnson and Johnso… CAPS Rating: ****
KMB $114.06 Up +0.15 +0.13%
Kimberly-Clark CAPS Rating: ****